Abbott Laboratories tops Q4 earnings

by

Yahoo Finance published this video item, entitled “Abbott Laboratories tops Q4 earnings” – below is their description.

#Abbott #yahoofinance #pharma

Yahoo Finance’s Anjalee Khemlani joins the Live show to break down fourth-quarter earnings for Abbott Laboratories.

Yahoo Finance YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.


About This Source - Yahoo Finance

Recent from Yahoo Finance:

Crypto, stablecoins, payment systems, and regulation: circle ceo weighs in from davos 1

Crypto, stablecoins, payment systems, and regulation: Circle CEO weighs in from Davos

Category: Business, Cryptocurrency, Finance

Geopolitical risks and the threat of AI: Business leaders weigh in from Davos, Switzerland

Category: Business, Finance

Investors slowly lose hope for Fed rate cuts in March

Category: Business, Finance

In This Story: Abbott Laboratories

Abbott Laboratories (NYSE: ABT) is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States.

3 Recent Items: Abbott Laboratories

‘FAILING GRADE’: Texas Democrat rips Kamala, praises Gov. Abbott on border

Category: News

Texas Gov. Abbott ‘has only stoked the flames of hatred and xenophobia,’ says San Antonio mayor

Category: News

Quinta Brunson REACTS to Her History-Making Emmys Win (Exclusive)

Category: Entertainment

Leave a Comment

We don't require your email address, or your name, for anyone to leave a comment. If you do add an email address, you may be notified if there are replies to your comment - we won't use it for any other purpose. Please make respectful comments, which add value, and avoid personal attacks on others. Links are not allowed in comments - 99% of spam comments, attempt to post links. Please describe where people may find additional information - for example "visit the UN website" or "search Google for..." rather than posting a link. Comments failing to adhere to these guidelines will not be published.